期刊
FRONTIERS IN CHEMISTRY
卷 9, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2021.678068
关键词
RiPPs; antibiotic; radical SAM enzyme; peptide; natural product (bio)synthesis; radical AdoMet enzyme; microbiome; microbiota
资金
- European Research Council, (ERC consolidator grant) [617053]
- ANR [ANR-17-CE11-0014, ANR-20-CE44-0005]
- European Research Council (ERC) [617053] Funding Source: European Research Council (ERC)
In order to address the antibiotic resistance crisis, novel strategies are urgently needed. Natural products have played a significant role in the discovery of new antibiotics, with ribosomally synthesized and posttranslationally modified peptides (RiPPs) being considered promising drug scaffolds. Recent studies have highlighted the important role of RiPPs in the human microbiota.
To face the current antibiotic resistance crisis, novel strategies are urgently required. Indeed, in the last 30 years, despite considerable efforts involving notably high-throughput screening and combinatorial libraries, only few antibiotics have been launched to the market. Natural products have markedly contributed to the discovery of novel antibiotics, chemistry and drug leads, with more than half anti-infective and anticancer drugs approved by the FDA being of natural origin or inspired by natural products. Among them, thanks to their modular structure and simple biosynthetic logic, ribosomally synthesized and posttranslationally modified peptides (RiPPs) are promising scaffolds. In addition, recent studies have highlighted the pivotal role of RiPPs in the human microbiota which remains an untapped source of natural products. In this review, we report on recent developments in radical SAM enzymology and how these unique biocatalysts have been shown to install complex and sometimes unprecedented posttranslational modifications in RiPPs with a special focus on microbiome derived enzymes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据